Monday, September 14, 2026

Tesla Soars as Trump Support Boosts Stock Prices

Tesla shares surged on news of Elon Musk's support for Trump, nearing a $1 trillion market cap amid expectations for regulatory approvals.

North Korean Women’s Club Makes First South Korea Visit in Eight Years for Inter-Korean AWCL Semifinal

North Korea's My Hometown Women's Football Club arrives in South Korea for the AFC Women's Champions League semifinals amid tensions.

North Korea Likely to Soon Announce 9th Party Congress Schedule… Expected to Continue Nuclear and Conventional Parallel Development Policy

North Korea's Workers' Party held a plenary meeting focusing on 9th Congress preparations, military strategy, and internal matters.

Tag: loss

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

New Study Reveals Radiation Dose Reduction May Cause Tumor Recurrence in Meningioma Patients

A study reveals that lower radiation doses for benign meningiomas near the optic nerve may lead to worse long-term outcomes and tumor regrowth.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

Unlocking Weight Loss: Hanmi Pharmaceutical’s Innovative H.O.P Project and the Game-Changing Epaglenatide

Hanmi Pharmaceutical is innovating obesity treatment with efpeglenatide and HM15275, focusing on tailored solutions for Korean patients.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

K-pop Star HyunA Reveals the One Exercise That Changed Her Body

K-pop star HyunA shares her weight loss journey, emphasizing walking and diet while noting important exercise precautions.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

Apple’s $3 Trillion Status Crashes After Trump Warning

Trump's tariff threat leads to a drop in Apple's stock, compounding challenges like declining Chinese sales and talent loss.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Nvidia Lost Half Its China Market—Now It’s Paying the Price

Nvidia CEO Jensen Huang criticized U.S. export controls on H20 chips to China, citing revenue losses and market share decline.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.